SuMarket

Oragenics Inc. OGEN

$0.52 -1.50% · NYSE American

Filings
  1. Aug 288-KTrouble signsreceived a delisting noticeSEC ↗
  2. Aug 1310-Qfiled its quarterly reportSEC ↗
  3. Jul 068-KDeals & acquisitionsentered a material agreementSEC ↗
  4. May 198-Kissued a regulatory disclosureSEC ↗
  5. May 0810-Qfiled its quarterly reportSEC ↗
  6. May 078-Kdisclosed another material eventSEC ↗
  7. Apr 138-Kdisclosed another material eventSEC ↗
  8. Mar 1610-Kfiled its annual reportSEC ↗
  9. Mar 118-Kdisclosed another material eventSEC ↗
  10. Jan 228-KDeals & acquisitionsentered a material agreementSEC ↗
  11. Jan 208-Kissued a regulatory disclosureSEC ↗
  12. Dec 158-KExecutive changesannounced an executive or director changeSEC ↗

OGEN’s dossier

A standing writeup of what the company does and how it is trading, kept current, with a dated note on every earnings, filing and unexplained move.

Dossiers are part of Pro. Price and filings above are free.

Reported financials

Revenue, margin and the balance sheet as the company reported them to the SEC.

Free · no card